Abbvie 3D HIV/HCV Coinfection Study - 300 enrollment
A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection (TURQUOISE-I).....Estimated enrollment: 300......Subject must be treatment naive or previous pegylated interferon/ribavirin treatment experienced....excluded: Prior therapy with direct acting antivirals for the treatment of HCV
